A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

Inclusion Criteria:

1. Male or female, 18-45 years old, inclusive;

2. BMI: 20.0 to 30.0 kg/m2 , body weight: ≥50.0kg.

3. Ability and willingness to participate in the study, give written informed consent,and comply with the study requirements and all protocol procedures.

Exclusion Criteria:

1. Presence of clinically significant conditions (including but not limited torespiratory system, cardiovascular system, gastrointestinal system, endocrinesystem, immune system, integumentary system, nervous system, ENT or other relateddiseases);

2. History of allergic diseases including asthma, urticaria or eczema, or history ofsensitivity to GLP-1 products, digoxin, warfarin, rosuvastatin or metformin;

3. Known difficulty in swallowing tablets or history of gastrointestinal diseasesaffecting drug absorption;

4. History of receiving any procedures that might affect drug absorption, distribution,metabolism or excretion;

5. History of acute or chronic pancreatitis;

6. History of documented or suspected hypoglycemic episodes within 6 months prior toscreening;